Endocannabinoids and nutrition

Journal of Neuroendocrinology

Volumn 20, Issue SUPPL. 1, 2008, Pages 94-99

  Hansen, Harold S ^a   Artmann, A ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

2 arachidonic acid; Anandamide; Diet; Eicosanoid formation; Endocannabinoid formation; Essential fatty acids; Levels; Oleoylethanolamide

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; ARACHIDONIC ACID; ENDOCANNABINOID; FISH OIL; LINOLEIC ACID; N OLEOYLETHANOLAMINE; PALMIDROL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

CONFERENCE PAPER; DIETARY INTAKE; ENERGY METABOLISM; ESSENTIAL FATTY ACID DEFICIENCY; FATTY ACID BLOOD LEVEL; FOOD INTAKE; GROWTH RETARDATION; HUMAN; LEARNING; LIPID DIET; LONG TERM EXPOSURE; MEMORY; NEUROTRANSMITTER RELEASE; NOCICEPTION; NONHUMAN; NUTRITION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SKIN WATER LOSS; STRUCTURE ANALYSIS; XERODERMA;

ANIMALS; ARACHIDONIC ACID; DIETARY FATS, UNSATURATED; EICOSANOIDS; ENDOCANNABINOIDS; FATTY ACIDS, UNSATURATED; HUMANS; MODELS, BIOLOGICAL; NUTRITION PHYSIOLOGY;

EID: 42349100360     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2008.01687.x     Document Type: Conference Paper

References (58)

1. Hansen HS, Jensen B, von Wettstein-Knowles P. Apparent in vivo retroconversion of dietary arachidonic to linoleic acid in essential fatty acid-deficient rats. Biochim Biophys Acta 1986; 878: 284-287.
2. Hansen HS. The essential nature of linoleic acid in mammals. Trends Biochem Sci 1986; 11: 263-265.
3. Hansen HS. Linoleic acid and epidermal water barrier. In: Galli C, Simopoulos AP, eds. Dietary w3 and W6 Fatty Acids: Biological Effects and Nutritional Essentiality. London: Plenum Press, 1989: 333-342.
4. Phinney SD, Clarke SD, Odin RS, Moldawer LL, Blackburn GL, Bistrian BR. Thermogenesis secondary to transdermal water loss causes growth retardation in essential fatty acid-deficient rats. Metabolism 1993; 42: 1022-1026.
5. Wheeler TG, Benolken RM, Anderson RE. Visual membranes: Specificity of fatty acid precursors for the electrical response to illumination. Science 1975; 188: 1313-1314.
6. Lauritzen L, Hansen HS, Jorgensen MH, Michaelsen KF. The essentiality of long chain n-3 fatty acids in relation to development and function of the brain and retina. Prog Lipid Res 2001; 40: 1-94.
7. Stubbs EB Jr, Carlson RO, Lee C, Fisher SK, Hajra AK, Agranoff BW. Essential fatty acid deficiency in cultured SK-N-SH human neuroblastoma cells. Adv Exp Med Biol 1992; 318: 171-182.
8. Urade R, Hayashi Y, Kito M. Monoenoic fatty acid requirement in V79 cells. J Biochem 1985; 97: 391-398.
9. Funk CD. Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science 2001; 294: 1871-1875.
10. Spector AA, Norris AW. Action of epoxyeicosatrienoic acids on cellular function. Am J Physiol Cell Physiol 2007; 292: C996-C1012.
11. 1α and the hepoxilins. Mol Neurobiol 2005; 32: 19-26.
12. Montuschi P, Barnes PJ, Roberts LJ II. Isoprostanes: Markers and mediators of oxidative stress. FASEB J 2004; 18: 1791-1800.
13. Zhou L, Nilsson Å. Sources of eicosanoid precursor fatty acid pools in tissues. J Lipid Res 2001; 42: 1521-1542.
14. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258: 1946-1949.
15. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, Vogel Z. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 1995; 50: 83-90.
16. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995; 215: 89-97.
17. Hansen HS, Petersen G, Artmann A, Madsen AN. Endocannabinoids. Eur J Lipid Sci Technol 2006; 108: 877-889.
18. Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of phamacotherapy. Pharmacol Rev 2006; 58: 389-462.
19. Sugiura T, Kishimoto S, Oka S, Gokoh M. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand. Prog Lipid Res 2006; 45: 405-446.
20. Matias I, Di Marzo V. Endocannabinoids and the control of energy balance. Trends Endocrinol Metab 2007; 18: 27-37.
21. Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ. The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 2007; 152: 1092-1101.
22. 2+ dependency for triggering retrograde endocannabinoid signal. Neuron 2005; 45: 257-268.
23. Katona I, Urban GM, Wallace M, Ledent C, Jung KM, Piomelli D, Mackie K, Freund TF. Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 2006; 26: 5628-5637.
24. Hansen HS, Moesgaard B, Petersen G, Hansen HH. Putative neuroprotective actions of N-acyl-ethanolamines. Pharmacol Ther 2002; 95: 119-126.
25. Hansen HS, Moesgaard B, Hansen HH, Petersen G. N-Acylethanolamines and precursor phospholipids - relation to cell injury. Chem Phys Lipids 2000; 108: 135-150.
26. Sun Y, Alexander SP, Garle MJ, Gibson CL, Hewitt K, Murphy SP, Kendall DA, Bennett AJ. Cannabinoid activation of PPARalpha; a novel neuroprotective mechanism. Br J Pharmacol 2007; 152: 734-743.
27. Lo Verme J, Gaetani S, Fu J, Oveisi F, Burton K, Piomelli D. Regulation of food intake by oleoylethanolamide. Cell Mol Life Sci 2005; 62: 708-716.
28. Darmani NA, Izzo AA, Degenhardt B, Valenti M, Scaglione G, Capasso R, Sorrentini I, Di Marzo V. Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: review of the available pre-clinical data, and first human studies. Neuropharmacology 2005; 48: 1154-1163.
29. Degn M, Lambertsen KL, Petersen G, Meldgaard M, Artmann A, Clausen BH, Hansen SH, Finsen B, Hansen HS, Lund TM. Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice. J Neurochem 2007; 103: 1907-1916.
30. Di Marzo V, Petrosino S. Endocannabinoids and the regulation of their levels in health and disease. Curr Opin Lipidol 2007; 18: 129-140.
31. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz J-C, Piomelli D. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994; 372: 686-691.
32. Su HM, Keswick LA, Brenna JT. Increasing dietary linoleic acid in young rats increases and then decreases docosahexaenoic acid in retina but not in brain. Lipids 1996; 31: 1289-1298.
33. Soriguer FJ, Tinahones FJ, Monzón A, Pareja A, Rojo-Martínez G, Moreno F, Esteva I, Gómez-Zumaquero JM. Varying incorporation of fatty acids into phospholipids from muscle, adipose and pancreatic exocrine tissues and thymocytes in adult rats fed diets rich in different fatty acids. Eur J Epidemiol 2000; 16: 585-594.
34. Emken EA, Adlof RO, Duval SM, Nelson GJ. Effect of dietary docosahexaenoic acid on desaturation and uptake in vivo of isotope-labeled oleic, linoleic, and linolenic acids by male subjects. Lipids 1999; 34: 785-791.
35. Hansen HS. Dietary essential fatty acids and in vivo prostaglandin production in mammals. World Rev Nutr Diet 1983; 42: 102-134.
36. Smit EN, Martini IA, Mulder H, Boersma ER, Muskiet FAJ. Estimated biological variation of the mature human milk fatty acid composition. Prostaglandins Leukot Essent Fatty Acids 2002; 66: 549-555.
37. Gebauer SK, Psota TL, Harris WS, Kris-Etherton PM. n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits. Am J Clin Nutr 2006; 83: 1526S-1535S.
38. Marckmann P, Lassen A, Haraldsdottir H, Sandström B. Biomarkers of habitual fish intake in adipose tissue. Am J Clin Nutr 1995; 62: 956-959.
39. Tjonneland A, Overvad K, Thorling E, Ewertz M. Adipose tissue fatty acids as biomarkers of dietary exposure in Danish men and women. Am J Clin Nutr 1993; 57: 629-633.
40. Hino A, Adachi H, Toyomasu K, Yoshida N, Enomoto M, Hiratsuka A, Hirai Y, Satoh A, Imaizumi T. Very long chain N-3 fatty acids intake and carotid atherosclerosis -an epidemiological study evaluated by ultrasonography. Atherosclerosis 2004; 176: 145-149.
41. Hansen HS, Fjalland B, Jensen B. Extremely decreased release of prostaglandin E2-like activity from chopped lung of ethyl linolenoate supplemented rats. Lipids 1983; 18: 691-695.
42. Rees D, Miles EA, Bannerjee T, Wells SJ, Roynette CE, Wahle KWJ, Calder PC. Dose-related effects of eicosapentaenoic acid on innate immune function in healthy humans: A comparison of young and older men. Am J Clin Nutr 2006; 83: 331-342.
43. Murphy KJ, Meyer BJ, Mori TA, Burke V, Mansour J, Patch CS, Tapsell LC, Noakes M, Clifton PA, Barden A, Puddey IB, Beilin LJ, Howe PR. Impact of foods enriched with n-3 long-chain polyunsaturated fatty acids on erythrocyte n-3 levels and cardiovascular risk factors. Br J Nutr 2007; 97: 749-757.
44. Ferretti A, Nelson GJ, Schmidt PC, Bartolini G, Kelley DS, Flanagan VP. Dietary docosahexaenoic acid reduces the thromboxane/prostacyclin synthetic ratio in humans. J Nutr Biochem 1998; 9: 88-92.
45. Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F, GISSI-Prevenzione I. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction -time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105: 1897-1903.
46. Wada M, DeLong CJ, Hong YH, Rieke CJ, Song I, Sidhu RS, Yuan C, Warnock M, Schmaier AH, Yokoyama C, Smyth EM, Wilson SJ, Fitzgerald GA, Garavito RM, Sui de X, Regan JW, Smith WL. Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem 2007; 282: 22254-22266.
47. Seyberth HW, Oelz O, Kennedy T, Sweetman BJ, Danon A, Frölich JC, Heimberg M, Oates JA. Increased arachidonate in lipids after administration to man: Effects on prostaglandin biosynthesis. Clin Pharmacol Ther 1975; 18: 521-529.
48. Ferretti A, Nelson GJ, Schmidt PC, Kelley DS, Bartolini G, Flanagan VP. Increased dietary arachidonic acid enhances the synthesis of vasoactive eicosanoids in humans. Lipids 1997; 32: 435-439.
49. Pantaleo P, Marra F, Vizzutti F, Spadoni S, Ciabattoni G, Galli C, La Villa G, Gentilini P, Laffi G. Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis. Clin Sci 2004; 106: 27-34.
50. 1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J Clin Invest 2005; 115: 1298-1305.
51. Berger A, Crozier G, Bisogno T, Cavaliere P, Innis S, Di Marzo V. Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N -acylethanolamines in piglets. Proc Natl Acad Sci U S A 2001; 98: 6402-6406.
52. Tsuyama S, Oikawa D, Yamasaki Y, Takagi S, Ando H, Furuse M. Expression of endocannabinoid synthetic enzyme mRNAs is correlated with cannabinoid 1 receptor mRNA in the mouse brain. Nutr Neurosci 2007; 10: 45-50.
53. Watanabe S, Doshi M, Hamazaki T. n-3 polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. Prostaglandins Leukot Essent Fatty Acids 2003; 69: 51-59.
54. Hanus L, Avraham Y, Ben Shushan D, Zolotarev O, Berry EM, Mechoulam R. Short-term fasting and prolonged semistarvation have opposite effects on 2-AG levels in mouse brain. Brain Res 2003; 983: 144-151.
55. Artmann A, Petersen G, Hellgren LI, Boberg J, Skonberg C, Hansen SH, Hansen HS. Influence of dietary fatty acids on endocannbinoid and n-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta (in press).
56. Rodriguez de Fonseca F, Navarro M, Gómez R, Escuredo L, Nava F, Fu J, Murillo-Rodríguez E, Giuffrida A, LoVerme J, Gaetani S, Kathuria S, Gall C, Piomelli D. An anorexic lipid mediator regulated by feeding. Nature 2001; 414: 209-212.
57. Nielsen MJ, Petersen G, Astrup A, Hansen HS. Food intake is inhibited by oral oleoylethanolamide. J Lipid Res 2004; 45: 1027-1029.
58. Kohsaka A, Laposky AD, Ramsey KM, Estrada C, Joshu C, Kobayashi Y, Turek FW, Bass J. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell Metab 2007; 6: 414-421.